Advisory Alpha’s BioTelemetry, Inc. BEAT Stock Holding History

Advisory Alpha’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9	Closed	–	–	729
2020 Q3	$0	Buy	+9	New	+$376	﹤0.01%	729

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Advisory Alpha's BEAT Position: Q4 2020 in Review

Advisory Alpha sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 9 shares.

Advisory Alpha first reported a position in BEAT in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

Advisory Alpha reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 9 BioTelemetry, Inc. shares in Q4 2020.
Advisory Alpha first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 1 quarter.
Advisory Alpha's BioTelemetry, Inc. position peaked at $0 in Q3 2020.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.